Cargando…

Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer

INTRODUCTION: Human cathelicidin antimicrobial protein, hCAP18, and its C-terminal peptide LL-37 is a multifunctional protein. In addition to being important in antimicrobial defense, it induces chemotaxis, stimulates angiogenesis and promotes tissue repair. We previously showed that human breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Günther, Chamorro, Clara Ibel, Granath, Fredrik, Liljegren, Annelie, Zreika, Sami, Saidak, Zuzana, Sandstedt, Bengt, Rotstein, Samuel, Mentaverri, Romuald, Sánchez, Fabio, Pivarcsi, Andor, Ståhle, Mona
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687709/ https://www.ncbi.nlm.nih.gov/pubmed/19183447 http://dx.doi.org/10.1186/bcr2221

Ejemplares similares

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Metal-Ion Interactions with Dodecapeptide Fragments of Human Cationic Antimicrobial Protein LL-37 [hCAP(134–170)]
por: Brzeski, Jakub, et al.
Publicado: (2022)

Enhanced resistance to bacterial and fungal pathogens by overexpression of a human cathelicidin antimicrobial peptide (hCAP18/LL-37) in Chinese cabbage
por: Jung, Yu-Jin, et al.
Publicado: (2011)

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
por: Dixon, Brian M, et al.
Publicado: (2012)

Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)(2)D(3) in hepatocellular carcinoma
por: Zhang, Huidan, et al.
Publicado: (2022)

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
por: Gürsoy, Ulvi K., et al.
Publicado: (2021)

Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro
por: Li, Dong, et al.
Publicado: (2013)

The human cathelicidin hCAP‐18 in serum of children with haemato‐oncological diseases
por: Jackmann, Natalja, et al.
Publicado: (2022)

Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)
por: Kim, Eun Sun, et al.
Publicado: (2018)

The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study
por: Ye, Ying, et al.
Publicado: (2015)

Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of cancer cells
por: Gambade, Audrey, et al.
Publicado: (2016)

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
por: Girnita, A, et al.
Publicado: (2011)

An Anilinoquinazoline Derivative Inhibits Tumor Growth through Interaction with hCAP-G2, a Subunit of Condensin II
por: Shiheido, Hirokazu, et al.
Publicado: (2012)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
por: Lim, Ratana, et al.
Publicado: (2013)

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
por: Mohanty, Soumitra, et al.
Publicado: (2021)

Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation
por: Boudot, Cédric, et al.
Publicado: (2017)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells
por: Wang, Aoxue, et al.
Publicado: (2014)

MicroRNA-132 promotes fibroblast migration via regulating RAS p21 protein activator 1 in skin wound healing
por: Li, Xi, et al.
Publicado: (2017)

Searching where the treasure is: on the emergence of human companion animal partnership (HCAP)
por: Miklósi, Ádám, et al.
Publicado: (2021)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

The antimicrobial peptide LL-37 triggers release of apoptosis-inducing factor and shows direct effects on mitochondria
por: Bankell, Elisabeth, et al.
Publicado: (2021)

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens
por: White, John Kerr, et al.
Publicado: (2022)

Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37
por: Kai-Larsen, Ylva, et al.
Publicado: (2010)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
por: Hwang, Young Ji, et al.
Publicado: (2014)

LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure
por: Sol, Asaf, et al.
Publicado: (2012)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uf5oijhqfdv0ost28dm2icd0oh